This search engine is the best way to find what you're after in METEOR, if you know what you're looking for. However, if you aren't sure what you're looking for, we suggest browsing the collection.

If you are using METEOR without an account, your search can be restricted by metadata item type, the main types of registration statuses, and by registration authority. It is also possible to search on METEOR ID number directly. You can save items of interest by adding bookmarks.

If you are logged in to METEOR as a metadata developer, you will have some additional options to restrict the search by. In addition to metadata item type and registration authority, you can restrict your search to the full range of registration status options, change date and workgroup. If you need access as a metadata developer and haven't done the training yet, please contact us.

When you type into the search box, you will get autocomplete suggestions. This predictive text will help you see the METEOR entries that exist for the topic you're searching on, and make your searching process faster and easier.

METEOR has a great many filters. The options directly below the search text box provide ways of limiting your search to all of the 18 content types in METEOR (see Learn about metadata to view the full list), item creation dates, and item revision dates. The 'Topic' content type will search the 'non-database' pages in METEOR, and 'Help' will search all of the 'information' pop-up information boxes that are linked to each item.

  • Content Types (eg data element, glossary item, value domain, data quality statement, indicator, classification scheme)
  • Created or Revision Dates (eg Last hour, Today, This week, Last month, This year, and specific date ranges)

To search the 'non-metadata' content of the METEOR website, such as the pages explaining what metadata items are, restrict your search results to 'Topic'.

You can also sort the results of your search on a range of options:

  • Relevance
  • Most / Least recently created
  • Most / Least recently updated
  • Alphabetical order (A–Z or Z–A)

You can further narrow down your results with the results categories that appear on the left side of the screen. These are: Registration Authority Status (Standard, Incomplete, Candidate, Superseded), Registration Authorities, Content Type, Stewards, Registration Statuses, and Submitting Organisations.

The 'Clear' button resets the Search page.

If you need to get finely-tuned results, this search engine uses Lucene search syntax. You can restrict your search to the titles of items by using Name: Searchterm, for instance, or hide words such as 'for' from the search by using backslashes, for example: \for\. Use "quote marks" to get an exact match with a word.

You can also use asterisks * for a wildcard search, which allows the search engine to replace any content with the asterisk. The METEOR wildcard search requires a precise format. It can only be inserted inside or at the end of a word, with at least one letter next to it (but not at the front of a word). The wildcard standing in isolation will also not work. For instance, ca*e* will bring up results for 'care', 'category', 'calendar' and 'cancer', while *cer or cancer * will not bring up any results.


Search

Showing 1-100 of 134 results
Pages 1 2 Page size:
Adverse event grade

467445 | Property | Cancer Australia
The grade/severity of any adverse event experienced during the course of clinical care.
Standard: Health

Androgen deprivation therapy indicator

587574 | Property | Cancer Australia
An indicator of the use of androgen deprivation therapy to reduce androgen hormones. This includes both chemical and surgical treatments.
Standard: Health

Androgen deprivation therapy purpose

505440 | Property | Cancer Australia
The purpose of androgen deprivation therapy use in treatment.
Standard: Health

Asbestos exposure indicator

428225 | Property | Cancer Australia
An indicator of whether an individual is known to have been exposed to asbestos.
Standard: Health

Asbestos exposure setting

520699 | Property | Cancer Australia
The setting in which exposure to asbestos is known to have occurred. Asbestos exposure may occur in the workplace, for example, in occupations related to mining, plumbing, electrical or construction material.Exposure may also occur in the home through, for example, exposure to asbestos housing construction material.
Standard: Health

Basis of diagnostic investigation

431353 | Property | Cancer Australia
The basis of diagnostic investigation at the time of first presentation. This relates to whether the patient was symptomatic at the time of first presentation, and if not, what first initiated the process of investigations leading to diagnosis.A symptom is any morbid phenomenon or departure from the normal in structure, function or sensation experienced by the patient and indicative of disease.
Standard: Health

Biopsy core number

587604 | Property | Cancer Australia
The number of biopsy cores from a single specimen pot examined as part of pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Brachytherapy dose rate

572803 | Property | Cancer Australia
The dose rate of brachytherapy. Brachytherapy is delivered by placing the radiation source in close proximity to the tumour site. The radioactive isotopes are sealed in tiny pellets or “seeds” which are placed in the body using delivery devices such as needles or catheters. Types include interstitial brachytherapy, which uses a source placed within tumour tissue, for example, within a prostate tumour; and intracavitary brachytherapy, whereby the source is placed within a surgical cavity or a bod...
Standard: Health

Cancer healthcare provider type

457918 | Property | Cancer Australia
The type of healthcare provider (individual, team or organisation) that provides primary cancer care.
Standard: Health

Cancer status

394063 | Property | Cancer Australia
Clinical evidence of the presence or absence of cancer. Clinical evidence describes the result of evaluation of a patient's physical condition and prognosis based on information gathered from physical examination, laboratory tests, imaging and the patient's medical history.
Standard: Health

Care coordinator assignment indicator

467844 | Property | Cancer Australia
An indicator of whether a care coordinator has been assigned. The role of a care coordinator is to achieve continuity of care and to ensure that care is delivered in a timely, logical and connected fashion so that both medical and personal needs are met.The assignment of a care coordinator is an indicator of the method of care that is being received.
Standard: Health

Castrate resistance date

587559 | Property | Cancer Australia
The date that two consecutive rising prostate-specific antigen levels (PSA) were found despite castrate levels of testosterone.
Standard: Health

Castrate resistance indicator

492861 | Property | Cancer Australia
An indicator outlining whether a rising prostate-specific antigen (PSA) level, or continued progression of prostate cancer despite castrate levels of testosterone, has been found.
Standard: Health

Chemotherapy completion date

393546 | Property | Cancer Australia
The date on which chemotherapy was completed. Chemotherapy is the treatment of disease by means of chemical substances or drugs; the term is usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are adm...
Standard: Health

Chemotherapy cycles administered

393825 | Property | Cancer Australia
The number of cycles of chemotherapy administered. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administer...
Standard: Health

Chemotherapy start date

413837 | Property | Cancer Australia
The date on which chemotherapy commenced. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administered in tr...
Standard: Health

Clinical trial entry status

430022 | Property | Cancer Australia
The status of clinical trial acceptance.
Standard: Health

Clinical trial experimental agent or intervention

487331 | Property | Cancer Australia
The experimental agent or intervention used in a clinical trial. A clinical trial is a controlled experiment involving a defined set of subjects and having a clinical event as an outcome measure. It is intended to yield scientifically valid information about the efficacy or safety of a medical intervention such as, for example, a drug, surgical procedure or diagnostic test.
Standard: Health

Clinical trial funding basis

467776 | Property | Cancer Australia
Whether a clinical trial is funded academically or by industry. Academic funding includes funding from academic institutions or government entities. Industry funding includes funding through private companies that are involved in the provision of pharmaceuticals or equipment that is used for clinical purposes.
Standard: Health

Clinical trial identifier

430961 | Property | Cancer Australia
The scientific/public title and/or registration number used to identify clinical trial(s).
Standard: Health

Core biopsy length

587536 | Property | Cancer Australia
The total length of biopsy cores collected from a single tissue specimen in pathology testing of a tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Core biopsy tumour extent

587551 | Property | Cancer Australia
The extent of tissue involved by cancer cells in a single specimen found in pathology testing of tissue. This includes both tissue biopsies and the collection of tissue related to other procedures.
Standard: Health

Core biopsy tumour length

587543 | Property | Cancer Australia
The total length of tissue involved by cancerous tissue in a single specimen found in pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Cytopathology result

425016 | Property | Cancer Australia
The result of the microscopic analysis of cells for the purpose of disease diagnosis.
Standard: Health

Date clinical trial completed

482211 | Property | Cancer Australia
The date a clinical trial for the treatment of person with cancer is completed.
Standard: Health

Date clinical trial entered

447311 | Property | Cancer Australia
The date on which a patient registers for a clinical trial.
Standard: Health

Date of cancer staging

568595 | Property | Cancer Australia
The date on which cancer staging is completed.Cancer staging is a system of determining the extent or stage of cancer. This date should be equal to the date that the latest pathological or clinical testing required to determine staging occurred. Should the staging be based on surgical findings the date should be equal to the date of the relevant surgery.
Standard: Health

Date of initial medical specialist consultation

456991 | Property | Cancer Australia
The date of the initial consultation with a medical specialist in relation to a specific disease-related symptom or suspected disease diagnosis.
Standard: Health

Date of initial primary health care consultation

456982 | Property | Cancer Australia
The date of the initial consultation with a general practitioner or primary health care practitioner in relation to a specific disease-related symptom or where the instance of a specific disease was first suspected.
Standard: Health

Date of last contact

394052 | Property | Cancer Australia
The date of the most recent contact with the patient.
Standard: Health

Date of referral to psychosocial services

448758 | Property | Cancer Australia
The date a patient was referred to psychosocial services.
Standard: Health

Date of referral to palliative care services

448608 | Property | Cancer Australia
The date a patient is referred to palliative care services. Palliative care is defined as the active total care of patients whose disease is not responsive to curative treatment and may include the control of pain and other symptoms, and of psychological, social and spiritual support. Referral to palliative care services is referral to palliative care administered by palliative care specialists such as a palliative care team or palliative physician. Palliative care may be administered in a com...
Standard: Health

Date of treatment outcome

572842 | Property | Cancer Australia
The date on which the outcome of a course of treatment provided for a particular condition is recorded.
Standard: Health

Depth of cervical cancer invasion

425540 | Property | Cancer Australia
The depth of invasion of a cervical cancer tumour into the cervical wall.
Standard: Health

Depth of myometrial invasion

425532 | Property | Cancer Australia
The depth of tumour invasion into the myometrium. The depth of myometrial invasion is assessed on microscopic examination and is measured from the normal endometrium-myometrium interface (not the surface of the intracavity or exophytic tumour) to the deepest tumour infiltrative focus.
Standard: Health

Diagnosis date of cancer

447400 | Property | Cancer Australia
The date on which cancer was first diagnosed.
Standard: Health

Diagnosis date of first recurrence as distant metastasis

447402 | Property | Cancer Australia
The date of first recurrence as distant metastatic disease. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease-free intermission or remission. Distant metastasis refers to the spread of cancer of the same histology as the original (primary) tumour to distant organs or distant lymph nodes.
Standard: Health

Diagnosis date of first recurrence as locoregional cancer

447405 | Property | Cancer Australia
The date of first recurrence as locoregional cancer. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease free period. Locoregional recurrence refers to the recurrence of cancer cells at the same site as the original (primary) tumour or the regional lymph nodes after a disease free period.
Standard: Health

Diagnostic histology indicator

487260 | Property | Cancer Australia
An indicator of whether a tissue specimen was collected and examined histologically.
Standard: Health

Diagnostic imaging type

431739 | Property | Cancer Australia
The type of medical imaging performed to confirm the diagnosis and determine the nature of a specific disease or condition.
Standard: Health

Diagnostic procedure type

431711 | Property | Cancer Australia
The procedures performed to determine the diagnosis and nature of a specific disease or condition.
Standard: Health

Distant metastatic cancer indicator

545183 | Property | Cancer Australia
An indicator of the existence of distant metastatic cancer. This may be determined through diagnostic or other imaging or procedures. Metastatic cancer is cancer which has spread from the initial site where it developed to other areas of the body. Which anatomical location is determined as a distant site will vary depending on the primary cancer type. Metastatic cancer is generally more common in aggressive cancer types and cancer which is left untreated for a longer period of time.
Standard: Health

Distant metastatic site(s) at diagnosis

433192 | Property | Cancer Australia
The anatomical position (topography) of the secondary or distant metastatic site(s) identified at the time of diagnosis of cancer.
Standard: Health

Distress status in past week

483585 | Property | Cancer Australia
The level of distress experienced over the past week.Distress includes unpleasant experiences of an emotional, psychological, social, or spiritual nature which interfere with the ability to cope.
Standard: Health

Erectile dysfunction assessment date

598102 | Property | Cancer Australia
The date that erectile dysfunction was assessed.
Standard: Health

Erectile dysfunction extent

598105 | Property | Cancer Australia
The degree of erectile dysfunction experienced.
Standard: Health

External beam radiotherapy type

468066 | Property | Cancer Australia
The type of external beam radiotherapy (XRT). The radiotherapy type relates to the planning target volume (PTV), the imaging type, and the radiotherapy beam arrangement.
Standard: Health

Extraprostatic extension focality

495226 | Property | Cancer Australia
The focality of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension indicator

587667 | Property | Cancer Australia
An indicator of the presence of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension location

587664 | Property | Cancer Australia
The location of extraprostatic extension (EPE) on the prostate.
Standard: Health

Faecal incontinence indicator

481973 | Property | Cancer Australia
An indicator of whether a person is experiencing faecal incontinence.
Standard: Health

Fertility counselling offered indicator

567255 | Property | Cancer Australia
An indicator of whether fertility counselling has been offered to an individual. This includes counselling about the potential outcomes of a disease, disorder or related treatment may have on long term fertility and the options in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Fertility counselling provided indicator

567309 | Property | Cancer Australia
An indicator of whether fertility counselling was provided. This includes counselling about the potential outcomes that a disease, disorder or treatment can have on their long term fertility and the options that they have in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Fertility preservation procedure indicator

462737 | Property | Cancer Australia
An indicator of whether a procedure has been performed for the purpose of preserving fertility. This may include the preservation of fertility related tissue or biological material (sperm, eggs or embryos), and/or hormone treatments.
Standard: Health

Fertility preservation procedure type

567412 | Property | Cancer Australia
The type of procedure performed for the purpose of preserving fertility. This may include the preservation of fertility related tissue or biological material (sperm, eggs or embryos), and/or hormone treatments.
Standard: Health

Fertility preservation utilised indicator

567511 | Property | Cancer Australia
An indicator of whether tissue preserved for purpose of fertility has been used.
Standard: Health

Gynaecological cancer post-radiotherapy complication indicator

546611 | Property | Cancer Australia
An indicator of the occurrence of treatment complications from radiotherapy for the treatment of gynaecological cancer.
Standard: Health

Hereditary genetic events type

564417 | Property | Cancer Australia
The type of genetic mutation that is passed down to further generations in a biological family.
Standard: Health

Hormone therapy completion date

393564 | Property | Cancer Australia
The date on which hormone therapy was completed. Hormone therapy is the treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Hormone therapy start date

393523 | Property | Cancer Australia
The date on which hormone therapy commenced. The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Immediate/short term treatment complication indicator

581057 | Property | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during clinical care.This includes, but is not limited to, complications from surgical treatment, such as an unplanned return to theatre, infection or haemorrhage, or complication from drug treatment, such as hypertension or toxicity.
Standard: Health

Immunohistochemistry type

432940 | Property | Cancer Australia
The type of immunohistochemistry stains used to assist in the identification of abnormal cells.
Standard: Health

Immunotherapy completion date

393580 | Property | Cancer Australia
The date on which immunotherapy was completed. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Immunotherapy start date

393536 | Property | Cancer Australia
The date on which immunotherapy commenced. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Individual Healthcare Identifier

432483 | Property | Cancer Australia
An identifier allocated by Medicare Australia that uniquely identifies each individual in the Australian healthcare system.
Standard: Health

Late effect indicator

469616 | Property | Cancer Australia
An indicator of whether a late effect appears after the acute stage of a disease or condition has resolved. This is as a result of the treatment, the disease process, or both.
Standard: Health

Late effect type

573455 | Property | Cancer Australia
The type of late effect experienced due to a disease and/or the associated treatment.
Standard: Health

Location of lymphovascular invasion

545101 | Property | Cancer Australia
The location of the invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Lymphovascular invasion indicator

519205 | Property | Cancer Australia
An indicator of whether there is evidence of the invasion of cancer cells into blood vessels and/or the lymphatic system in the pathology specimen.
Standard: Health

Lymphovascular invasion type

430038 | Property | Cancer Australia
The type of invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Molecular pathology indicator

435162 | Property | Cancer Australia
An indicator of whether molecular pathology testing was performed to determine the characteristics of a person's medical condition.
Standard: Health

Molecular pathology test date

519350 | Property | Cancer Australia
The date on which a molecular pathology test is performed to determine the characteristics of a person's medical condition.
Standard: Health

Molecular pathology test results

428389 | Property | Cancer Australia
The results of a molecular pathology test for genetic and molecular abnormalities. In a clinical environment these results will inform the appropriate patient treatment pathway.
Standard: Health

Multidisciplinary team review indicator

428242 | Property | Cancer Australia
An indicator of whether a patient's treatment was discussed and planned at a multidisciplinary team meeting. The multidisciplinary team should consist of the core disciplines required for the provision of good patient care, which will vary by disease type.
Standard: Health

Multiple primary tumours descriptor

433391 | Property | Cancer Australia
Whether the multiple primary tumours in the person with cancer are synchronous or metachronous. Synchronous primary tumours are detected simultaneously, either preoperatively or in the resected specimen. Metachronous primary tumours are detected after a time interval between detection of the first lesion and detection of a subsequent primary lesion.
Standard: Health

Multiple primary tumours indicator

519542 | Property | Cancer Australia
An indicator of whether multiple primary tumours are present.
Standard: Health

Myometrial thickness

545252 | Property | Cancer Australia
The total thickness of the myometrium, i.e. the middle layer of tissue in the uterine wall.
Standard: Health

Other cancer treatment

403842 | Property | Cancer Australia
Treatments used for the treatment of cancer other than surgery, radiotherapy or systemic therapy.
Standard: Health

Pelvic lymph node dissection indicator

587594 | Property | Cancer Australia
An indicator of the occurrence of a pelvic lymph node dissection. Pelvic lymph node dissection is completed for the purpose of determining lymph node metastasis in cancer. This procedure is most commonly used in prostate and bladder cancers.
Standard: Health

Pelvic lymph node dissection laterality

494382 | Property | Cancer Australia
The laterality of the dissection of a pelvic lymph node for the purpose of determining lymph node metastasis in cancer. This procedure is most commonly used in prostate and bladder cancers.
Standard: Health

Performance status score at diagnosis

412353 | Property | Cancer Australia
A score given at the time of diagnosis outlining the extent to which a person’s disease affects their daily living abilities. This is based on assessment by a treating health professional. Performance status at diagnosis is an important prognostic indicator which is used to determine appropriate treatment, assess how the disease has progressed, and for the statistical analyses of outcome adjusted by performance status.
Standard: Health

Perineural invasion indicator

429128 | Property | Cancer Australia
An indicator of whether perineural invasion is evident in a pathology specimen.Perineural invasion refers to cancer cells tracking along or around a nerve within the space surrounding a nerve.
Standard: Health

Personal genetic syndrome indicator

457068 | Property | Cancer Australia
An indicator of whether an individual has been diagnosed with a genetic syndrome. A genetic syndrome is set of symptoms that are caused by a specific gene/genetic mutation.
Standard: Health

Personal genetic syndrome type

564768 | Property | Cancer Australia
The specific type of genetic syndrome with which the person has been diagnosed.A genetic syndrome is a syndrome which is caused by a genetic abnormality/mutation.
Standard: Health

Positive biopsy core number

587527 | Property | Cancer Australia
The number of biopsy cores found positive for cancer in pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Post-initial surgery residual tumour size

425577 | Property | Cancer Australia
The size of the residual tumour remaining after the initial surgery for treatment purposes.
Standard: Health

Pregnancy outcome indicator

593393 | Property | Cancer Australia
An indicator of whether a person or if male, their partner, has carried a pregnancy to term, including a live birth.
Standard: Health

Primary course of chemotherapy delay indicator

542946 | Property | Cancer Australia
An indicator of whether the primary course of chemotherapy has been delayed.
Standard: Health

Primary course of chemotherapy delay reason

450832 | Property | Cancer Australia
The reason for a delay in the primary course of chemotherapy.
Standard: Health

Primary surgical treatment complication indicator

546451 | Property | Cancer Australia
An indicator of the occurrence of treatment complications within 30 days of primary surgery.
Standard: Health

Prostate-specific antigen test date

587683 | Property | Cancer Australia
The date that a test assessing the level of prostate-specific antigen (PSA) in a person's blood stream was taken.
Standard: Health

Prostate-specific antigen test level

481433 | Property | Cancer Australia
The level of prostate-specific antigen (PSA) in the blood stream.
Standard: Health

Psychosocial services type

519999 | Property | Cancer Australia
The type of psychosocial service a person is referred to as part of their cancer treatment or follow-up.
Standard: Health

Radiotherapy completion date

394467 | Property | Cancer Australia
The date on which radiotherapy was completed. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health

Radiotherapy fractions administered

393508 | Property | Cancer Australia
The number of radiotherapy fractions or treatment sessions administered. Radiotherapy is the treatment of disease by means of ionizing radiation. Administration of the total dose of radiation is spread out over time and delivered to the patient in a number of even parts or treatment sessions (fractions). Although a treatment session may include several treatment portals delivered within a confined period of time, usually a few minutes, it is still considered one fraction.
Standard: Health

Radiotherapy start date

393479 | Property | Cancer Australia
The date on which radiotherapy commenced. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health, WA Health

Radiotherapy target site

414605 | Property | Cancer Australia
The site or region of the body where radiotherapy is administered. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health

Reason(s) second-line treatment administered

457424 | Property | Cancer Australia
The reason(s) second-line treatment, treatment that was not part of the planned initial course of treatment, was administered.
Standard: Health

Reason(s) treatment not administered

428269 | Property | Cancer Australia
The reason(s) treatment was not administered for a particular condition or disease.
Standard: Health

Referral to psychosocial services indicator

431244 | Property | Cancer Australia
An indicator of whether a patient has been referred to psychosocial services. The psychosocial needs of patients vary with their circumstances; however, most patients will experience some degree of practical, psychological and emotional challenges as a result of their diagnosis and treatment-related adverse effects. For instance, patients undergoing treatment may experience fear, anxiety and depression, while managing the demands of work and family with the demands of treatment may create enormo...
Standard: Health

Pages 1 2 Page size: